Table 2. Success and complications of enrolled studies.

Study	Frequency (SW/min)	Frequency Categorya	No. of Patients	No. of Success (%)	Criterion of Success	No. of Complication (%)	Clavien grade
							I	II	III	IV
Pace et al [19]	60	Low	111	82 (73.9)	< 5 mm	12 (10.8)	10	1	1	0
	120	High	109	66 (60.6)		21 (19.3)	19	1	1	0
Yilmaz et al [20]	60	Low	57	51 (89.5)	< 3 mm	0 (0)	0	0	0	0
	90	Intermediate	57	50 (87.7)		0 (0)	0	0	0	0
	120	High	56	41 (73.2)		1 (1.8)	1	0	0	0
Madbouly et al [5]	60	Low	76	75 (98.7)	< 2 mm	NA	N/A
	120	High	80	72 (90.0)		NA	N/A
Davenport et al [21]	60	Low	49	29 (59.2)	< 4 mm	5 (10.2)	N/A
	120	High	51	31 (60.8)		4 (7.8)	N/A
Li et al [29]	90	Intermediate	57	38 (66.7)	< 3 mm	5 (8.8)	5	0	0	0
	120	High	59	27 (45.8)		6 (10.2)	6	0	0	0
Honey et al [22]	60	Low	77	50 (64.9)	Stone free	9 (11.7)	5	3	1	0
	120	High	86	42 (48.8)		6 (7.0)	4	1	1	0
Koo et al [23]	70	Low	51	35 (68.6)	Stone free	NA	N/A
	100	High	51	14 (27.5)		NA	N/A
Mazzucchi et al [26]	60	Low	143	76 (53.1)	≤ 3 mm	7 (4.9)	6	1	0	0
	90	Intermediate	157	86 (54.8)		10 (6.4)	7	3	0	0
Chang et al [25]	60	Low	81	57 (70.4)	< 4 mm	NA	N/A
	120	High	80	46 (57.5)		NA	N/A
Ng et al [24]	60	Low	103	52 (50.5)	< 4 mm	14 (13.6)	14	0	0	0
	120	High	103	37 (35.9)		23 (22.3)	23	0	0	0
Anglada-Curado et al [27]	60	Low	78	78 (100)	Stone free	NA	N/A
	80	Intermediate	72	67 (93.1)		NA	N/A
Salem et al [30]	80	Intermediate	30	27 (90.0)	< 3 mm	4 (13.3)	0	4	0	0
	120	High	30	22 (73.3)		2 (6.7)	0	2	0	0
Nguyen et al [28]	60	Low	127	101 (79.5)	Stone free	13 (10.2)	6	2	1	4
	90	Intermediate	113	103 (91.2)		17 (15.0)	4	1	5	7

a. Frequency ranges were defined as high-frequency (100–120 SWs/minute), intermediate-frequency (80–90 SWs/minute), and low-frequency (60–70 SWs/ minute).